FIELD: organic chemistry, pharmacy. SUBSTANCE: invention relates to a novel derivative of benzothiazolone of the formula (I) 
and (II) 
where X means naphthyl and its pharmaceutically acceptable salts. Method of synthesis of compound of the formula (I) involves selective reduction of compound of the formula (II). Compounds of the formula (I) can be used for synthesis of medicinal agent for treatment of patients with diseases or respiratory ways, for example, asthma and chronic bronchitis. EFFECT: synthesis of new derivative of benzothiazolone, valuable medicinal properties. 8 cl, 1 tbl, 1 ex
| Title |
Year |
Author |
Number |
| BENZOTHIAZOLONE COMPOUNDS, METHODS AND INTERMEDIATE COMPOUNDS FOR THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF |
1996 |
- Rodzher Viktor Bonnert
- Rodzher Charl'Z Braun
- Piter Alan Kehjdzh
- Frehnsis Ins
- Garri Perodo
|
RU2172313C2 |
| DERIVATIVES OF 7-(2-AMINOETHYL)-BENZOTHIAZOLONE OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHODS OF THEIR SYNTHESIS, DERIVATIVES OF N-[2-(4-HYDROXY-2-OXO-3H-1,3-BENZOTHIAZOLE-7-YL]-ETHYLAMIDE, PHARMACEUTICAL COMPOSITION SHOWING AGONISTIC ACTIVITY RELATIVE TO β-ADRENORECEPTORS |
1993 |
- Rodzher Viktor Bonnert
- Dehvid Rehnalf Cheshir
- Rodzher Charl'Z Braun
- Frehnsis Ins
|
RU2114108C1 |
| COMBINATION OF MUSCARINE RECEPTOR ANTAGONIST AND BETA-2-ADRENORECEPTOR AGONIST |
2008 |
- Finch Garri
- Uili Kehtrin
- Dikson Dzhon
|
RU2460527C2 |
| DERIVATIVES OF 3-H-1,2,3-TRIAZOLO-[4,5-D]-PYRIMIDINE, PHARMACEUTICAL COMPOSITION AND METHOD OF THEIR SYNTHESIS |
1996 |
- Koks Dehvid
- Ingoll Ehntoni
- Uillis Pol
|
RU2174518C2 |
| NOVEL 951 COMPOUNDS: BIPHENYLOXYPROPANOIC ACID AS CRTh2 RECEPTOR MODIFIER AND INTERMEDIATE COMPOUNDS |
2008 |
- Bonnert Rodzher Viktor
- Luker Timoti Dzhon
- Pehjtel Anil
- Rigbi Aaron
|
RU2472785C2 |
| NUCLEOTIDE ANALOG-CONTAINING PHARMACEUTICAL COMPOSITION AND METHOD FOR IT PREPARING |
1998 |
|
RU2216330C2 |
| PYRIMIDOPYRIDAZINE DERIVATIVES APPLICABLE AS P38 MAP KINASE |
2010 |
- Besvik Amanda
- Vashkovych Bogdan
|
RU2516466C2 |
| HYDANTOIN DERIVATIVES USED AS MMP INHIBITORS |
2007 |
- Chapman Dehvid
- Gabos Balint
- Munk Av Rozenshold Magnus
|
RU2463301C2 |
| MONO-SODIUM SALT 5-[[(2,3-DIFLUOROPHENYL)METHYL]THIO]-7-[[2-HYDROXY-1-(HYDROXYMETHYL)-1-METHYETHYL]AMINO]-THIAZOLE[4,5-d]PYRIMIDINE-2(3H)-ON AS MODULATOR OF ACTIVENESS OF CHEMOKINE RECEPTORS, ITS APPLICATIONS AND PHARMACEUTICAL COMPOSITION |
2003 |
|
RU2342389C2 |
| XINAFOATE SALT OF N4-[(2,2-DIFLUORO-4H-BENZO[1,4]OXAZIN-3-ON)-6-YL]-5-FLUORO-N2-[3-(METHYLAMINOCARBONYL METHYLENEOXY)PHENYL]-2,4-PYRIMIDINE DIAMINE |
2008 |
- Tehjlor Stefan Kolin Dzhon
|
RU2458925C2 |
